Whitehawk Therapeutics Inc (WHWK)
WHWK Stock Price Chart
Explore Whitehawk Therapeutics Inc interactive price chart. Choose custom timeframes to analyze WHWK price movements and trends.
WHWK Company Profile
Discover essential business fundamentals and corporate details for Whitehawk Therapeutics Inc (WHWK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
1 Aug 2017
Employees
40.00
Website
https://ir.whitehawktx.comCEO
David J. Lennon
Description
Whitehawk Therapeutics Inc operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers.
WHWK Financial Timeline
Browse a chronological timeline of Whitehawk Therapeutics Inc corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 5 Nov 2025
EPS estimate is -$0.48, while revenue estimate is $33.33M.
Earnings released on 7 Aug 2025
EPS came in at -$0.76 falling short of the estimated $0.49 by -255.10%.
Earnings released on 8 May 2025
EPS came in at -$0.36 surpassing the estimated -$0.46 by +21.74%, while revenue for the quarter reached $7.15M .
Earnings released on 18 Mar 2025
EPS came in at -$0.67 falling short of the estimated -$0.22 by -204.55%, while revenue for the quarter reached $7.24M .
Stock split effective on 27 Aug 2021
Shares were split 15 : 1 , changing the number of shares outstanding and the price per share accordingly.
WHWK Stock Performance
Access detailed WHWK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.